AMERIPRISE FINANCIAL INC - AEGERION PHARMACEUTICALS INC ownership

AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 15 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 4.7%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$8,351,000
-10.5%
12,460,0000.0%0.00%
-20.0%
Q4 2018$9,329,000
-0.1%
12,460,0000.0%0.01%
+66.7%
Q3 2018$9,336,000
+15.5%
12,460,0000.0%0.00%
-25.0%
Q2 2018$8,086,000
-16.5%
12,460,0000.0%0.00%0.0%
Q1 2018$9,687,000
-2.2%
12,460,0000.0%0.00%
-20.0%
Q4 2017$9,906,000
-0.4%
12,460,0000.0%0.01%0.0%
Q3 2017$9,948,000
-0.3%
12,460,0000.0%0.01%0.0%
Q2 2017$9,973,000
-1.5%
12,460,0000.0%0.01%0.0%
Q1 2017$10,130,000
-0.0%
12,460,000
-12.0%
0.01%
-16.7%
Q4 2016$10,131,000
+27.2%
14,160,000
+17.4%
0.01%
+50.0%
Q3 2016$7,962,000
+17.2%
12,060,0000.0%0.00%0.0%
Q2 2016$6,796,000
-25.0%
12,060,000
-33.2%
0.00%
-20.0%
Q1 2016$9,063,000
-55.3%
18,060,000
-40.8%
0.01%
-58.3%
Q4 2015$20,266,000
-16.2%
30,490,000
-4.3%
0.01%
-20.0%
Q3 2015$24,176,00031,870,0000.02%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Context Capital Management, LLC 1,500,000$1,219,0000.82%
EdgePoint Investment Group Inc. 51,642,000$41,704,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,600,000$13,359,0000.60%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 43,150,000$34,952,0000.52%
Tekla Capital Management LLC 13,000,000$10,303,0000.37%
UBS OCONNOR LLC 26,000,000$20,669,000,0000.30%
Orbimed Advisors 15,000,000$12,151,0000.12%
Baker Brothers Advisors 9,517,000$7,576,0000.06%
CSS LLC/IL 653,000$517,0000.02%
Allianz Asset Management GmbH 28,680,000$23,232,0000.02%
View complete list of AEGERION PHARMACEUTICALS INC shareholders